Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Oliver J. Mueller"'
Autor:
Bernadin Ndongson Dongmo, Jan Magnus Aronsen, Gaia Calamera, Mette Ovesen, Dulasi Arunthavarajah, Kristin N. Smeby, Arne O. Melleby, Oliver J. Mueller, Jean Piero Margaria, Alessandra Ghigo, Emilio Hirsch, Lise Román Moltzau, Jérôme Leroy, Rodolphe Fischmeister, Kjetil Wessel Andressen, Finn Olav Levy
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:150-151
Wie lassen sich potentielle kardiotoxische Schäden in der onkologischen Behandlung vermeiden? Die verbesserte Diagnostik und Therapie onkologischer Erkrankungen führt auch zu neuen Herausforderungen in der Herz- und Kreislaufmedizin. Hierbei sind n
Autor:
Oliver J Mueller, Norbert Frey, Janek Salatzki, Johannes Riffel, Lorenz H. Lehmann, Benjamin Meder, Daniel Finke, Hugo A. Katus, Florian Leuschner, Markus B Heckmann, Esther Herpel, Ziya Kaya
Publikováno v:
Circulation. 142
Introduction: Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment. Nevertheless, their increasing clinical use leads to higher rates of adverse immune related events (irAEs). One of those irAEs is the ICI-induced myocarditis (ICI
Autor:
Tianke Wang, Oliver J. Mueller, Craig T. Basson, Andrea Feller, Elizabeth V Ratchford, Mustafa M Shennak, Ping Chen, Sigrid Nikol, Kerry S Russell, John Hoekstra, Lucy LaPerna, Timothy Clough, Christopher M. Kramer, Marek Piatek, Laurence Colin, Thomas Forst, Holger Lawall, William B. Smith, Denise Yates
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Background: Peripheral artery disease (PAD) affects 8.5 million people in the US. PAD patients are at high risk for cardiovascular events, and their quality of life is often significantly impaired by decreased mobility. Interleukin-1β (IL-1β) may p
Autor:
Britta Vogel, Anna Strothmeyer, Oliver J. Mueller, Benjamin Meder, Erwin Blessing, Stefan E. Hardt, Daniel Saure, Martin Zeier, Vedat Schwenger, Felicitas Stoll, Hugo A. Katus, Michael Kirchberger, Martin Andrassy
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 103(2)
Renal sympathetic denervation (RDN) is a novel treatment option in patients with treatment-resistant arterial hypertension. A subset of recently published randomized and non-randomized trials indicates that RDN leads to sustained lowering of blood pr
Autor:
Hugo A. Katus, Tobias Daniel Trippel, Norbert Frey, Henning Witt, Matthias Lutz, Elvis Tahirovic, Evangelos Giannitsis, Hans-Dirk Düngen, Oliver J. Mueller, Tanja Weis, Philipp Schatz, Matthias Mueller
Publikováno v:
Journal of the American College of Cardiology. 63:A784